(Total Views: 275)
Posted On: 03/11/2022 10:55:49 AM
Post# of 53
$CAPR News Article - The Lancet Publishes Positive Results from Capricor Therapeutics' Phase 2 Study Evaluating CAP-1002 in Late-Stage Duchenne Muscular Dystrophy https://marketwirenews.com/news-releases/the-...26977.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼